The S&P 500 Index (SPX) generated “unusually strong” return during the first three quarters of 2024 – compared to the ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday, covering ...

Amazon’s satellite broadband initiative, Project Kuiper, shows huge potential. Find out why AMZN stock could thrive with a ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

He went 5-for-11 from beyond the arc, making it the second-most 3s he has made in a single game this season behind a 6-for-9 ...

Is the Premier League about to witness the latest triumphant return of Jose Mourinho (actual triumph to be confirmed)? He's ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...

Over the past two weeks, few teams have been as hot as the Detroit Pistons. Following another victory, their star player gave ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

Russo also swept our club awards last month, clinching the Goal of the Month and women's Player of the Month accolades. She ...

Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports. The firm owned 84,477 shares of the ...